Mercator MedSystems, a San Leandro, CA-based medical technology company, closed a $6.5m Series B financing.
The round was co-led by Volcano Capital, Crocker Capital and Aphelion Capital, with participation from Windy City Inc. and SET Technology Gmbh. In conjunction with the financing, Volcano Capital partner Doug Wall, Aphelion Capital’s founder Ned Scheetz, and Windy City’s President Joel Kanter will join the Board of Directors.
Led by Chief Executive Officer Thomas M. Loarie, and Kirk P. Seward, Ph.D., Chief Science and Technology Officer, Mercator MedSystems spun out of The University of California, Berkeley in 2000 to develop catheter-guided micro-infusion systems for targeted delivery of drugs and biologics to treat the root cause of significant medical conditions, including cardiovascular disease, oncology, hypertension and heart disease.
The company intends to use the funds to initiate sales of its Cricket™ and Bullfrog® Micro-Infusion devices in Europe, the United States and Australia – and support clinical validation of its product platform to treat peripheral artery disease (PAD).